Childrens Loratadine Tablet, Chewable
Product Images NDC 69842-954

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Childrens Loratadine (NDC 69842-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs Pharmacy, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mg Tablet Blister Pack Carton)

Principal Display Panel (5 mg Tablet Blister Pack Carton)
This is a description of a CVS allergy relief product called "Children's Allergy Relief Loratadine Chewable Tablets USP". The product contains an antihistamine called Loratadine USP, 5 mg, and is used to temporarily relieve allergy symptoms such as sneezing, runny nose, itchy and watery eyes, and itchy throat or nose due to hay fever or other upper respiratory allergies. The chewable tablets are intended for children 2 years and older, and the recommended dosage is two tablets per day for children 6 years and over, and one tablet per day for children aged 2 to under 6. This product should not be taken more than directed, as taking more than the recommended dosage may cause drowsiness. The carton should be kept as it contains important information, including the expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.